Pandey, S NVaidya, R AIrani, A2003-04-102009-05-302003-04-102009-05-302003-04-10Pandey SN, Vaidya RA, Irani A. Growth hormone treatment in a girl with Prader Willi syndrome. Indian Journal of Pediatrics. 2003 Apr; 70(4): 351-3http://imsear.searo.who.int/handle/123456789/84115Prader Willi syndrome (PWS) is a rare endocrine-metabolic disorder that is characterised by neonatal hypotonia, hyperphagia, marked obesity, short stature, hypogonadism and behavioural problems. 7-20% percent of these children develop diabetes mellitus. A large number of individuals with PWS show growth hormone (GH) deficiency. Recent studies indicate beneficial effects of GH replacement therapy not only for their linear growth but also for correction of metabolic dysfunction. In the present communication this article details about the therapeutic outcome in a girl with PWS who received recombinant growth hormone (rGH), Genotropin. Some carry-over therapeutic benefits have been observed even after discontinuation of rGH.engAdolescentFemaleGlucose Tolerance TestGrowth --drug effectsHuman Growth Hormone --bloodHumansPituitary Hormones, Anterior --bloodPrader-Willi Syndrome --bloodRecombinant Proteins --therapeutic useTreatment OutcomeCase Reports